Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.24.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Account and other receivables, net of allowance $ 72 $ 7
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 250,000,000 250,000,000
Common stock, shares issued 5,320,671 542,145
Common stock, shares outstanding 5,320,671 542,145
Series B Convertible Preferred Stock [Member]    
Convertible preferred stock, par value $ 0.01 $ 0.01
Convertible preferred stock, shares authorized 130,000,000 130,000,000
Convertible preferred stock, shares issued 26 26
Convertible preferred stock, shares outstanding 26 26
Series C Convertible Preferred Stock [Member]    
Convertible preferred stock, par value $ 0.01 $ 0.01
Convertible preferred stock, shares authorized 130,000,000 130,000,000
Convertible preferred stock, shares issued 50 50
Convertible preferred stock, shares outstanding 50 50
Series D Convertible Preferred Stock [Member]    
Convertible preferred stock, par value $ 0.01 $ 0.01
Convertible preferred stock, shares authorized 130,000,000 130,000,000
Convertible preferred stock, shares issued 180 206
Convertible preferred stock, shares outstanding 180 206
Series E Convertible Preferred Stock [Member]    
Convertible preferred stock, par value $ 0.01 $ 0.01
Convertible preferred stock, shares authorized 130,000,000 130,000,000
Convertible preferred stock, shares issued 0 1
Convertible preferred stock, shares outstanding 0 1